Salt-inducible kinases inhibitor HG-9-91-01 targets RIPK3 kinase activity to alleviate necroptosis-mediated inflammatory injury.
Huang D, Chen P, Huang G, Sun H, Luo X, He C, Chen F, Wang Y, Zeng C, Su L, Zeng X, Lu J, Li S, Huang D, Gao H, Cao M.
Huang D, et al. Among authors: su l.
Cell Death Dis. 2022 Feb 25;13(2):188. doi: 10.1038/s41419-022-04633-y.
Cell Death Dis. 2022.
PMID: 35217652
Free PMC article.